Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 14

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Skaningowy mikroskop sil [SFM] i jego zastosowanie w badaniach biologicznych

100%
Pyka-Fosciak G., Grybos J.
Wszechświat
|
2003
|
tom 104
|
nr 04-06
106-108
2

Organisation and development of the gonads in viviparous and oviparous generations of Stomaphis quercus (INsecta, Hemiptera, Aphidinea: Lachnidae)

100%
Pyka-Fosciak G., Szklarzewicz T.
Acta Biologica Cracoviensia. Series Botanica. Supplement
|
2004
|
tom 46
|
nr 1
3

Structure of ovaries of Stomaphis quaercus [Insecta, Hemiptera, Aphidinea: Lachnidae] and Phylloxera sp. [Insecta, Hemiptera, Aphidinea: Phylloxeridae]

81%
Szklarzewicz T., Pyka-Fosciak G., Szarota A., Wieczorek K.
Acta Biologica Cracoviensia. Series Botanica. Supplement
|
2006
|
tom 48
|
nr 1
70
4

Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis

81%
Pyka-Fosciak G., Stasiolek M., Litwin J. A.
Folia Histochemica et Cytobiologica
|
2018
|
tom 56
|
nr 3
5

LN-5 antibody against human macrophages cross-reacts with routinely processed human sebaceous glands

81%
Lis G. J., Litwin J. A., Furgal-Borzych A., Pyka-Fosciak G.
Folia Histochemica et Cytobiologica
|
2012
|
tom 50
|
nr 2
6

Morphology and ultrastructure of the ovary of Steingelia gorodetskia (Insecta,Hemiptera, Coccinea: Steingeliidae)

81%
Szklarzewicz T., Koteja J., Pyka-Fosciak G., Vogelgesang M.
Acta Biologica Cracoviensia. Series Botanica. Supplement
|
2004
|
tom 46
|
nr 1
7
Content available remote

Effect of natalizumab treatment on metalloproteinases and their inhibitors in a mouse model of multiple sclerosis

81%
Pyka-Fosciak G., Lis G. J., Litwin J. A.
Journal of Physiology and Pharmacology
|
2020
|
tom 71
|
nr 2
8

Ultrastructural studies on the formation of egg envelopes in fulgoromorphans [Insecta, Hemiptera, Fulgoromorpha: Dictyopharidae]

80%
Pyka-Fosciak G., Jankowska W., Szklarzewicz T.
Folia Biologica
|
2003
|
tom 51
|
nr 3-4
9
Content available remote

Effect of nebivolol treatment on atherosclerotic plaque components in apoE-knockout mice

71%
Pyka-Fosciak G., Jawien J., Gajda M., Jasek E., Litwin J. A.
Journal of Physiology and Pharmacology
|
2013
|
tom 64
|
nr 6
10
Content available remote

AVE 0991 - angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE - knockout mice

51%
Toton-Zuranska J., Gajda M., Pyka-Fosciak G., Kus K., Pawlowska M., Niepsuj A., Wolkow P., Olszanecki R., Jawien J., Korbut R.
Journal of Physiology and Pharmacology
|
2010
|
tom 61
|
nr 2
Recent evidence shows that the renin-angiotensin system is a crucial player in atherosclerotic processes. It was also proved that Ang II promotes atherogenesis. Angiotensin-(1-7) [Ang-(1-7)] opposites Ang II action. Therefore, we would like to find out whether Ang-(1-7) receptor agonist: AVE 0991, could ameliorate atherosclerosis progression in an experimental model of atherosclerosis: apolipoprotein E (apoE) - knockout mice. AVE 0991 inhibited atherogenesis, measured both by “en face” method (7.63±1.6% vs. 14.6±2.1%) and “cross-section” method (47 235±7 546 µm2 vs. 91 416±8 357 µm2). This is the first report showing the effect of AVE 0991 on atherogenesis in gene-targeted mice.
11
Content available remote

The effect of nebivolol on atherogenesis in apoE - knockout mice

42%
Kus K., Gajda M., Pyka-Fosciak G., Toton-Zuranska J., Pawlowska M., Suski M., Niepsuj A., Nowak B., Wolkow P., Olszanecki R., Jawien J., Korbut R.
Journal of Physiology and Pharmacology
|
2009
|
tom 60
|
nr 4
163-165
Nebivolol is a novel beta1-blocker with a nitric oxide (NO) - potentiating, vasodilatory effect that is unique among beta-blockers. It was already shown that nebivolol ameliorates atherosclerosis in cholesterol-fed rabbits. We, therefore, wanted to investigate whether this is the case in the fine experimental model of atherosclerosis: apolipoprotein E (apoE)- knockout mice. Nebivolol attenuated atherogenesis, measured both by "en face" method (9.23±1.8% vs. 14.6±2.1%) and "cross-section" method (63125±8455 µm2 vs. 91416±8357 m2). This is the first report showing the effect of nebivolol on atherogenesis in gene-targeted mice.
12
Content available remote

The effect of doxycycline on atherogenesis in apoE-knockout mice

42%
Pawlowska M., Gajda M., Pyka-Fosciak G., Toton-Zuranska J., Niepsuj A., Kus K., Bujak-Gizycka B., Suski M., Olszanecki R., Jawien J., Korbut R.
Journal of Physiology and Pharmacology
|
2011
|
tom 62
|
nr 2
Doxycycline at subantimicrobial doses inhibits matrix metalloproteinases (MMPs) activity, and is the only MMP inhibitor which is widely available in clinical practice. The aim of the study was to reveal whether non-specific MMPs inhibition by tetracycline could ameliorate development of atherosclerosis in apolipoprotein E (apoE)-knockout mice. Doxycycline (1.5 mg/ kg b.w./day) administered orally attenuated atherogenesis, measured both by "en face" method (10.25±1.7% vs. 15.7±2.0%, p<0.05) and "cross-section" method (66,254±7,468 µm2 vs. 90,687±8,521 µm2, p<0.05). In-situ zymography showed decrease of the extent of non-specific gelatinase activity in doxycycline-treated mice This is the first report to date describing the effect of doxycycline on atherogenesis in apoE-targeted mice.
13
Content available remote

Vasodilatory effect and endothelial integrity in papaverine- and milrinone-treated human radial arteries

42%
Rudzinski P., Wegrzyn P., Lis G. J., Piatek J., Konstanty-Kalandyk J., Nosalski R., Mikolajczyk T., Jasinska M., Pyka-Fosciak G., Guzik T., Litwin J. A., Korbut R., Sadowski J.
Journal of Physiology and Pharmacology
|
2013
|
tom 64
|
nr 1
14
Content available remote

Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice

42%
Jawien J., Toton-Zuranska J., Gajda M., Niepsuj A., Gebska A., Kus K., Suski M., Pyka-Fosciak G., Nowak B., Guzik T. J., Marcinkiewicz J., Olszanecki R., Korbut R.
Journal of Physiology and Pharmacology
|
2012
|
tom 63
|
nr 1
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.